The WACC of Apellis Pharmaceuticals Inc (APLS) is 7.6%.
| Range | Selected | |
| Cost of equity | 6.80% - 8.80% | 7.80% |
| Tax rate | 0.10% - 0.20% | 0.15% |
| Cost of debt | 4.00% - 7.00% | 5.50% |
| WACC | 6.6% - 8.7% | 7.6% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.64 | 0.71 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.80% | 8.80% |
| Tax rate | 0.10% | 0.20% |
| Debt/Equity ratio | 0.1 | 0.1 |
| Cost of debt | 4.00% | 7.00% |
| After-tax WACC | 6.6% | 8.7% |
| Selected WACC | 7.6% | |